您当前所在的位置:首页 > 产品中心 > 产品信息
Sulfanilamide_分子结构_CAS_63-74-1)
点击图片或这里关闭

Sulfanilamide

产品号 DB00259 公司名称 DrugBank
CAS号 63-74-1 公司网站 http://www.ualberta.ca/
分子式 C6H8N2O2S 电 话 (780) 492-3111
分子量 172.20492 传 真
纯 度 电子邮件 david.wishart@ualberta.ca
保 存 Chembase数据库ID: 144

产品价格信息

请登录

产品别名

标题
Sulfanilamide
IUPAC标准名
4-aminobenzene-1-sulfonamide
IUPAC传统名
sulfanilamide
商标名
Pysococcine
White Streptocide
Sulfanidyl
Streptocidum
Sulphanilamide Extra Pure
Sulfanilamide Vaginal Cream
Sulfonamide
Copticide
Deseptyl
Dipron
Prontalbin
Rubiazol A
Septamide Album
Septinal
Streptocide White
Sulfamine
Sulfanalone
Antistrept
Bacteramid
Erysipan
Exoseptoplix
Gerison
Orgaseptine
Prontosil I
Pronzin Album
Sanamid
Septanilam
Septoplix
Strepsan
Streptamid
Streptol
Streptosil
Streptrocide
Sulfamidyl
Sulfana
Sulfocidin
Sulfocidine
Sulfonamide P
Sulphanilamide Gr
Therapol
AVC
Albexan
Albosal
Ambeside
Astreptine
Astrocid
Bactesid
Colsulanyde
Desseptyl
Ergaseptine
Estreptocida
Fourneau 1162
Gombardol
Infepan
Lusil
Lysococcine
Neococcyl
Prontosil Album
Prontylin
Proseptal
Proseptine
Septolix
Septoplex
Stramid
Strepamide
Streptagol
Streptamin
Streptasol
Streptocid Album
Streptocide
Streptoclase
Streptocom
Strepton
Streptopan
Streptozol
Streptozone
Sulfanil
Tolder
Collomide
HSDB 223
Prontosil White
Proseptol
Stopton Album
Streptocid
别名
Sulfanilimidic Acid
P-Sulfamidoaniline
P-Aminobenzenesulfamide
P-Aminophenylsulfonamide
P-Aminobenzensulfonamide
P-Aminobenzenesulfonylamide
PABS
Sulphanilamide
P-Sulfamoylaniline
P-Anilinesulfonamide
P-Aminobenzenesulfonamide
Sulfonylamide
Sulphonamide

产品登记号

PubChem CID 5333
CAS号 63-74-1
PubChem SID 46508306

产品性质

疏水性(logP) -0.8
溶解度 7500 mg/L

产品详细信息

详细说明 (English)
Item Information
Drug Groups approved
Description Sulfanilamide is a molecule containing the sulfonamide functional group attached to an aniline. [Wikipedia]
Indication For the treatment of vulvovaginitis caused by Candida albicans.
Pharmacology Sulfanilamide is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.
Toxicity Oral, mouse LD50 = 3700 mg/kg; Intravenous, mouse LD50 = 621 mg/kg; Oral, rabbit LD50 = 1300 mg/kg. Side effects include itching, burning, skin rash, redness, swelling, or other sign of irritation not present before use of this medicine and long-term use of sulfonamides may cause cancer of the thyroid gland.
Affected Organisms
Candida albicans and other yeasts
Absorption Sulfonamides are absorbed through the vaginal mucosa. There are no pharmacokinetic data available describing how much of an intravaginal dose reaches the systemic circulation.
References
Nzila A: Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discov Today. 2006 Oct;11(19-20):939-44. Epub 2006 Sep 7. [Pubmed]
External Links
Wikipedia
Drugs.com

参考文献

  • Nzila A: Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discov Today. 2006 Oct;11(19-20):939-44. Epub 2006 Sep 7. Pubmed